SGLT2 Inhibitor-Associated Ketoacidosis Vs Type 1 Diabetes-Associated Ketoacidosis.
JAMA network open(2024)
Abstract
This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor-associated ketoacidosis compared with that of type 1 diabetes-associated ketoacidosis.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined